Gabrail Cancer Center

Phase	Trial	Trial Status	Site Status	Drug [asc]	NCT#
3	Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)	Recruiting	Active	Velzatinib	NCT07585266